CRISPR Innovations in Nephrology

Explore how CRISPR-Cas9 gene-editing technology is reshaping the future of kidney disease treatment by targeting mutations responsible for disorders like polycystic kidney disease (PKD) and focal segmental glomerulosclerosis (FSGS). Learn about current breakthroughs in gene editing, delivery mechanisms using nanoparticles, and their potential in personalized nephrology therapies. This track will delve into the latest advancements in in vivo and ex vivo gene correction techniques for renal cells, as well as the role of CRISPR in functional genomics to uncover new therapeutic targets. Attendees will evaluate the safety, efficiency, and long-term effects of CRISPR interventions in kidney models, and gain insights into the translational pathway from bench to bedside for CRISPR-based nephrology solutions.

    Related Conference of CRISPR Innovations in Nephrology

    August 28-29, 2025

    10th World Kidney Congress

    London, UK
    November 03-04, 2025

    29th European Nephrology Conference

    Rome, Italy
    December 10-11, 2025

    12th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 09-10, 2026

    17th Nephrology,Renal Medicine & Renal Care

    Dubai, UAE
    March 26-27, 2026

    22nd World Nephrology Conference

    Amsterdam, Netherlands
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France

    CRISPR Innovations in Nephrology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in